MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 6 analysts with an average price target of $17.18. This is a potential upside of $9.43 (121.68%) from yesterday's end of day stock price of $7.75.

Mersana Therapeutics's activity chart (see below) currently has 48 price targets and 47 ratings on display. The stock rating distribution of MRSN is 72.73% BUY and 27.27% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.28% with an average time for these price targets to be met of 257.17 days.

Highest price target for MRSN is $36, Lowest price target is $30, average price target is $24.33.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 14-Aug-2025. First documented stock forecast 24-Jul-2017.

Currently out of the existing stock ratings of MRSN, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$36

$28.25 (364.52%)

$10

10 days ago
(14-Aug-2025)

0/4 (0%)

$28.58 (385.18%)

Buy

$30

$22.25 (287.10%)

$5

10 days ago
(14-Aug-2025)

3/5 (60%)

$22.58 (304.31%)

556

1 years 5 months 26 days ago
(29-Feb-2024)

1/3 (33.33%)

$10.19 (175.39%)

28

Buy

$7

$-0.75 (-9.68%)

$2

1 years 5 months 26 days ago
(29-Feb-2024)

4/5 (80%)

$1.56 (28.68%)

274

1 years 5 months 26 days ago
(29-Feb-2024)

0/2 (0%)

$10.19 (175.39%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 257.17 days on average for the stock forecasts to be realized with a an average price target met ratio 40.28

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Michael Ulz works at BAIRD and has 12 price targets and 6 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Asthika Goonewardene with highest potential upside - $28.25

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

Ashik Kurian with lowest potential downside - -$6.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?